Salesforce (NYSE:CRM) and Slack have filed an antitrust lawsuit in the UK against Microsoft, challenging the bundling of Teams with other Microsoft pr...
Former employees at AI giants are raising hundreds of millions of dollars from investors months on from launching.
The telecom giant's latest results highlighted impressive growth and strong guidance, further securing its robust dividend.
Elon Musk's landmark $150 billion lawsuit against OpenAI and Microsoft moved closer to trial as jury selection concluded on Monday.
Crypto exchanges, finance, and cybersecurity stocks could dip if a Mythos-related attack occurs.
Microsoft and OpenAI have agreed to end Azure cloud exclusivity for OpenAI models and remove revenue sharing between the companies. The revised agreem...
It may not seem like it at first, but these dividends are safe.
While the top- and bottom-line numbers for Verizon (VZ) give a sense of how the business performed in the quarter ended March 2026, it could be worth ...
Wall Street is beginning to price in companies that can build a fully domestic rare earth supply chain, as a 2027 defense deadline forces the U.S. to ...
REVIEW PREVIEW NEWSLETTER Expectations Mount. It’s a big week for earnings, and investors are feeling optimistic as S&P 500 companies plow through wha...
During a 2007 onstage conversation at a conference, Steve Jobs revived one of his favorite stories about Apple Inc.’s former CEO, Gil Amelio. Jobs sai...
Can Nvidia's stock price recovery last?
It's going to be a busy week on Wall Street as several leading "Magnificent Seven" and crypto companies report their quarterly earnings. The Magnifice...
Himadri Speciality Chemical’s fair value has been kept steady at ₹470.0 per share, even as the underlying model assumptions for growth, margins, and d...
Chipmaker Nvidia (NVDA) has seen a strong rally recently, but not everyone on Wall Street believes it can keep going at the same pace. Indeed, JPMorga...
Four Mag 7 giants will report on Wednesday at the same time, along with other hot stocks like Carvana. Get ready.
The AI chipmaker has rebounded from its recent correction, but is there additional upside ahead?
An analyst initiated coverage of the biotech.
Rambus (NASDAQ:RMBS) outlined its second-quarter outlook and provided updates on product transitions, supply chain conditions, and longer-term platfor...
The company has made a proposal to acquire a top European peer.
Loading...